 Cyclosporin A (CSA) nephrotoxicity is a common problem after cardiac transplantation. We have studied the impact of CSA dose reduction in association with mycophenolate mofetil (MMF) treatment on renal function in heart transplant recipients with suspected CSA nephrotoxicity (serum creatinine >2mg/dl).   
